276 related articles for article (PubMed ID: 27088457)
61. Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.
Luo L; Qin T; Huang Y; Zheng S; Bo R; Liu Z; Xing J; Hu Y; Liu J; Wang D
Drug Deliv; 2017 Nov; 24(1):1099-1111. PubMed ID: 28776443
[TBL] [Abstract][Full Text] [Related]
62. A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4
Sahu R; Dixit S; Verma R; Duncan SA; Coats MT; Giambartolomei GH; Singh SR; Dennis VA
Nanomedicine; 2020 Oct; 29():102257. PubMed ID: 32610072
[TBL] [Abstract][Full Text] [Related]
63. Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.
Hu Y; Hoerle R; Ehrich M; Zhang C
Acta Biomater; 2015 Dec; 28():149-159. PubMed ID: 26428192
[TBL] [Abstract][Full Text] [Related]
64. Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach.
Rose F; Wern JE; Ingvarsson PT; van de Weert M; Andersen P; Follmann F; Foged C
J Control Release; 2015 Jul; 210():48-57. PubMed ID: 25957906
[TBL] [Abstract][Full Text] [Related]
65. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
[TBL] [Abstract][Full Text] [Related]
66. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
Sarti F; Perera G; Hintzen F; Kotti K; Karageorgiou V; Kammona O; Kiparissides C; Bernkop-Schnürch A
Biomaterials; 2011 Jun; 32(16):4052-7. PubMed ID: 21377204
[TBL] [Abstract][Full Text] [Related]
67. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
68. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
69. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.
Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A
J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403
[TBL] [Abstract][Full Text] [Related]
70. Potentiating Antigen Specific Immune Response by Targeted Delivery of the PLGA-Based Model Cancer Vaccine.
Jahan ST; Sadat SMA; Yarahmadi M; Haddadi A
Mol Pharm; 2019 Feb; 16(2):498-509. PubMed ID: 30477303
[TBL] [Abstract][Full Text] [Related]
71. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
[TBL] [Abstract][Full Text] [Related]
72. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
73. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
Mohanan D; Gander B; Kündig TM; Johansen P
Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
[TBL] [Abstract][Full Text] [Related]
74. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
75. Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint.
Kim SR; Ho MJ; Lee E; Lee JW; Choi YW; Kang MJ
Int J Nanomedicine; 2015; 10():5263-71. PubMed ID: 26345227
[TBL] [Abstract][Full Text] [Related]
76. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
Front Immunol; 2017; 8():1077. PubMed ID: 28955328
[TBL] [Abstract][Full Text] [Related]
77. PEI-modified macrophage cell membrane-coated PLGA nanoparticles encapsulating Dendrobium polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Zhang Z; Li D; Li X; Guo Z; Liu Y; Ma X; Zheng S
Int J Biol Macromol; 2020 Dec; 165(Pt A):239-248. PubMed ID: 32979446
[TBL] [Abstract][Full Text] [Related]
78. Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice.
Mansoor F; Earley B; Cassidy JP; Markey B; Foster C; Doherty S; Welsh MD
Res Vet Sci; 2014 Jun; 96(3):551-7. PubMed ID: 24726021
[TBL] [Abstract][Full Text] [Related]
79. Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles.
Giarra S; Serri C; Russo L; Zeppetelli S; De Rosa G; Borzacchiello A; Biondi M; Ambrosio L; Mayol L
Carbohydr Polym; 2016 Apr; 140():400-7. PubMed ID: 26876867
[TBL] [Abstract][Full Text] [Related]
80. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
